This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,292,000.00 to the University of California, San Francisco (UCSF) to conduct in vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer. The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical investigations. The 4-year research project will involve basic, applied, and advanced studies to develop new diagnostic and therapeutic approaches for liver cancer. As a leading research institution, UCSF has a strong track record of collaborating with federal agencies like the Department of Defense on high-impact biomedical research projects.
Generated 6/11/24, 4:00 AM